Post-marketing Re-evaluation of Tongxiening Granules (痛泻宁颗粒) in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial

Xudong Tang, Shengsheng Zhang, Xiaohua Hou, Zhenhua Li, Suning Chen, Pei-min Feng, Xiaonan Yang, Huizhen Li, Jieqiong Wu, Pei-jun Xia, Xiaojun Yang, Hengjun Zhou, Haiyan Wang, Yaowei Ai, Kang LiChinese 2019 · DOI

BibTeX
@inproceedings{tang2019post,
  author = {Xudong Tang and Shengsheng Zhang and Xiaohua Hou and Zhenhua Li and Suning Chen and Pei-min Feng and Xiaonan Yang and Huizhen Li and Jieqiong Wu and Pei-jun Xia and Xiaojun Yang and Hengjun Zhou and Haiyan Wang and Yaowei Ai and Kang Li},
  title = {{Post-marketing Re-evaluation of Tongxiening Granules (痛泻宁颗粒) in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial}},
  booktitle = {Chinese},
  year = {2019},
  doi = {10.1007/s11655-019-3030-x},
}

Loading related content...

Figure